Option Care Health (OPCH)
(Real Time Quote from BATS)
$27.44 USD
+0.46 (1.71%)
Updated Jul 10, 2024 03:30 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Income Statements
Fiscal Year end for Option Care Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 4,302 | 3,945 | 3,439 | 3,033 | 2,310 |
Cost Of Goods | 3,321 | 3,078 | 2,659 | 2,350 | 1,797 |
Gross Profit | 981 | 867 | 780 | 682 | 513 |
Selling & Adminstrative & Depr. & Amort Expenses | 667 | 627 | 589 | 572 | 513 |
Income After Depreciation & Amortization | 315 | 240 | 191 | 111 | 0 |
Non-Operating Income | 95 | 19 | -7 | -8 | -4 |
Interest Expense | 51 | 54 | 67 | 108 | 74 |
Pretax Income | 359 | 206 | 116 | -5 | -78 |
Income Taxes | 92 | 55 | -23 | 3 | -2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 267 | 151 | 140 | -8 | -76 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 267 | 151 | 140 | -8 | -76 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 381 | 310 | 265 | 194 | 62 |
Depreciation & Amortization (Cash Flow) | 67 | 70 | 74 | 83 | 62 |
Income After Depreciation & Amortization | 315 | 240 | 191 | 111 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 180.38 | 182.08 | 179.36 | 201.90 | 154.94 |
Diluted EPS Before Non-Recurring Items | 1.48 | 0.83 | 0.60 | -0.04 | -0.19 |
Diluted Net EPS (GAAP) | 1.48 | 0.83 | 0.77 | -0.04 | -0.49 |
Fiscal Year end for Option Care Health, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 1,146.05 | 1,124.39 | 1,093.01 | 1,069.07 |
Cost Of Goods | NA | 907.55 | 877.27 | 838.75 | 818.24 |
Gross Profit | NA | 238.50 | 247.12 | 254.27 | 250.83 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 169.47 | 162.56 | 173.22 | 168.46 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 69.03 | 84.56 | 81.05 | 82.37 |
Non-Operating Income | NA | 1.13 | 6.80 | 0.82 | 86.33 |
Interest Expense | NA | 13.20 | 12.43 | 11.79 | 13.20 |
Pretax Income | NA | 56.96 | 78.93 | 70.09 | 155.50 |
Income Taxes | NA | 12.16 | 21.75 | 13.78 | 41.10 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 44.79 | 57.18 | 56.30 | 114.40 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 44.79 | 57.18 | 56.30 | 114.40 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 175.62 | 177.74 | 180.53 | 181.24 |
Diluted EPS Before Non-Recurring Items | NA | 0.26 | 0.32 | 0.31 | 0.63 |
Diluted Net EPS (GAAP) | NA | 0.26 | 0.33 | 0.31 | 0.63 |